REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/29/2025
Back to search
Official data from USPTO
ATTACKING CANCER IS NOW PERSONAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ATTACKING CANCER IS NOW PERSONAL
ST13
US500000086905042Class
44
Filing
86905042
Registration
5092892
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
11/30/2025
Trademark type
Word
Nice classes
44
Filing date
02/11/2016
Registration date
11/29/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/10/2022
Last transaction
11/30/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/31/2015
First use in commerce
05/31/2015
Drawing code
4
Owner type
03
Owner location
Salt Lake City, UT
Examiner
FRISCH,HANNA CHO
Law office
L50
Current location
TMEG LAW OFFICE 105
Holders and representatives
Holders
IHC Health Services, Inc.
Representatives
Joshua G. Gigger STOEL RIVES LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical servicesproviding personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis and treatment purposes; providing genetic sequencing and consulting services designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing servicesidentifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive programs involving drug therapy and physician support services in the nature of providing consultation in the dispensing of prescription drugs for persons with particular cancers
Publications
History of USPTO decisions and trademark events.
25 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/10/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/10/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/10/2022
E815
TEAS SECTION 8 & 15 RECEIVED
02/22/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/29/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/29/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/27/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/26/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/12/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/11/2016
IUAF
USE AMENDMENT FILED
09/21/2016
EISU
TEAS STATEMENT OF USE RECEIVED
09/21/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2016
PUBO
PUBLISHED FOR OPPOSITION
07/12/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/22/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/27/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
05/27/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/27/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
05/27/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/27/2016
DOCK
ASSIGNED TO EXAMINER
05/27/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/18/2016
NWAP
NEW APPLICATION ENTERED
02/15/2016
Continuous trademark protection
Get notified about every new filing that threatens ATTACKING CANCER IS NOW PERSONAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.